BCG vaccine
- Generic Name
- BCG vaccine
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 8VJE55B0VG
- Background
BCG vaccine has been investigated for the treatment of Neoplasms, Bladder Cancer, Neoplasms by Site, Urologic Diseases, and Urologic Neoplasms, among others.
- Associated Conditions
- Non-Invasive Bladder Urothelial Carcinoma, Recurrent Superficial Bladder Cancer, Tuberculosis (TB), Urothelial Carcinoma Recurrent, Carcinoma in situ of urinary bladder
- Associated Therapies
- -
Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa
- Conditions
- Interventions
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- HIV Vaccine Trials Network
- Target Recruit Count
- 276
- Registration Number
- NCT05947890
- Locations
- 🇿🇦
Cape Town - Khayelitsha, Cape Town, South Africa
🇿🇦Durban - Botha's Hill CRS, Durban, Kwa Zulu Natal, South Africa
🇿🇦Johannesburg - CHRU, Westdene, Gauteng,, South Africa
BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants
- Conditions
- Interventions
- First Posted Date
- 2023-07-13
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 100
- Registration Number
- NCT05943106
- Locations
- 🇺🇸
Research Site, Spokane, Washington, United States
Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer
- First Posted Date
- 2023-01-09
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- National and Kapodistrian University of Athens
- Target Recruit Count
- 100
- Registration Number
- NCT05675176
- Locations
- 🇬🇷
Themistoklis Bellos, Marathon, Attica, Greece
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
- Conditions
- Interventions
- First Posted Date
- 2022-11-23
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Al-Azhar University
- Target Recruit Count
- 280
- Registration Number
- NCT05626101
- Locations
- 🇪🇬
Mohamed Fawzy Salman, Cairo, Egypt
Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly
- First Posted Date
- 2021-06-24
- Last Posted Date
- 2022-07-06
- Lead Sponsor
- Harvard Medical School (HMS and HSDM)
- Registration Number
- NCT04938323
BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST)
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2021-06-28
- Lead Sponsor
- Harvard Medical School (HMS and HSDM)
- Registration Number
- NCT04534803
Propranolol Adjuvant Treatment of Bladder Cancer
- Conditions
- Interventions
- First Posted Date
- 2020-07-30
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- Central South University
- Target Recruit Count
- 242
- Registration Number
- NCT04493489
BCG Vaccine for Health Care Workers as Defense Against COVID 19
- Conditions
- Interventions
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Texas A&M University
- Target Recruit Count
- 659
- Registration Number
- NCT04348370
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Texas A&M Family Care Clinic, Bryan, Texas, United States
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
- First Posted Date
- 2020-03-31
- Last Posted Date
- 2022-06-03
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 1511
- Registration Number
- NCT04328441
- Locations
- 🇳🇱
Sint Maartenskliniek, Nijmegen, Gelderland, Netherlands
🇳🇱Radboud UMC, Nijmegen, Gelderland, Netherlands
🇳🇱Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
BCG Vaccination to Protect Healthcare Workers Against COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-03-31
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 6828
- Registration Number
- NCT04327206
- Locations
- 🇦🇺
Prince of Wales Hospital, Sydney, New South Wales, Australia
🇦🇺Westmead Hospital, Sydney, New South Wales, Australia
🇧🇷Fundação de Medicina Tropical Dr Heitor Vieira Dourado (FMT-HVD), Manaus, Amazonas, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.